Panacea Biotec (BOM:531349) Gross-Profit-to-Asset % : 27.96% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Panacea Biotec's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹3,468 Mil. Panacea Biotec's average Total Assets over the quarter that ended in Mar. 2024 was ₹12,407 Mil. Therefore, Panacea Biotec's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 27.96%.

Panacea Biotec Gross-Profit-to-Asset % Historical Data

The historical data trend for Panacea Biotec's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Gross-Profit-to-Asset % Chart

Panacea Biotec Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

26.22

30.31

24.47

13.68

26.20

Panacea Biotec Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															22.48	23.39	26.67	26.15	27.96

Competitive Comparison of Panacea Biotec's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Panacea Biotec's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Biotec's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Gross-Profit-to-Asset % falls into.

Panacea Biotec Gross-Profit-to-Asset % Calculation

Panacea Biotec's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2024 )	/	( (Total Assets (A: Mar. 2023 )	+	Total Assets (A: Mar. 2024 ))	/ count )
	=	3290.5	/	( (12711.66	+	12406.8)	/ 2 )
	=	3290.5	/	12559.23
	=	26.20 %

Panacea Biotec's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	3468.4	/	( (0	+	12406.8)	/ 1 )
	=	3468.4	/	12406.8
	=	27.96 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Panacea Biotec Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec (BOM:531349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines